The ageing population and increased demand for healthcare products and services across the globe are creating great opportunities for businesses in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. At the same time the delivery of global healthcare is changing fast and creating significant opportunities for private providers.

At Clearwater International we have the knowledge, experience, track record and reach to help companies exploit these growing global opportunities. Given these dynamics it’s a market which remains a rich source of M&A deal flow and corporate activity as private providers take advantage of outsourcing opportunities and investors seek to consolidate market positions. Our sector team works closely with innovative companies who are at the forefront of the healthcare revolution, advising businesses on their strategies for dealing with governments seeking to drive efficiencies and improve patient experiences.


Sector Comments

Healthcare Sector Comment – August 2017 – Specialist Care Services

Over the last 12 months we have seen close to 50 deals complete globally in the Specialist Care Services market, which includes treatment for patients with learning disabilities, mental health issues, and neurological and developmental conditions, such as Asperger’s and … Find out more…

Healthcare Sector Comment – June 2017 – Medical Devices

This month we saw Becton Dickinson and Co. (BD) announce its intention to acquire C. R. Bard Inc. (CRB), the medical technology company specialising in vascular, urological and oncological products, for €18.3bn. The deal comes two years after BD acquired … Find out more…

Healthcare sector comment – May 2017 – Pharma

We are increasingly seeing consolidation within big pharma as the largest players focus on their core services and outsource non-core services. This is a trend that has not gone unnoticed by investors and they have mostly been investing their money … Find out more…